IBI308 in Subjects With Advanced/Metastatic Solid Malignancies
Clinical trial NCT03568539 · COMPLETED
Trial details
- NCT number
- NCT03568539
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2020-11-09
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.